<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0020">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Abdel-Mohsen</surname>
    <given-names>HT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abd El-Meguid</surname>
    <given-names>EA</given-names>
   </name>, 
   <name name-style="western">
    <surname>El Kerdawy</surname>
    <given-names>AM</given-names>
   </name>, 
   <etal>etÂ al.</etal>
  </person-group>
  <article-title>Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer</article-title>. 
  <source>Arch Pharm (Weinheim)</source>
  <year>2020</year>;
  <volume>353</volume>:
  <fpage>e1900340</fpage>.
  <pub-id pub-id-type="pmid">32045054</pub-id>
 </mixed-citation>
</ref>
